1. United Kingdom Stocks

  2. •

    Consumer Defensive

  3. •

    Packaged Foods
Anpario plc

Anpario plc

ANP.L
Anpario plcGB flagLondon Stock Exchange
548.00
GBp
-5.00
- -
90.75MMarket Cap
Anpario plc
ANP.L
(London Stock Exchange)

Recent

price

548.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
1.18
1.06
1.3
1.42
1.27
1.19
1.21
1.44
1.38
1.41
1.5
1.63
1.62
1.66
2.29
- -
Revenue per Share
0.07
0.09
0.12
0.14
0.17
0.19
0.13
0.15
0.2
0.18
0.21
0.23
0.16
0.14
0.25
- -
Basic EPS, GAAP
-0.07
0.07
0.1
0.11
0.13
0.12
0.11
0.22
0.04
0.11
0.22
0.08
-0.02
0.42
0.23
- -
Free Cash Flow per Basic Share
0.01
0.02
0.02
0.03
0.04
0.05
0.05
0.08
0.07
0.08
0.08
0.1
0.11
0.09
0.11
- -
Dividend per Share
0.37
0.71
0.8
0.91
1.04
1.14
1.2
1.26
1.38
1.48
1.61
1.74
1.8
1.4
1.71
- -
Book Value per Share
0.43
0.49
0.49
0.59
0.7
0.83
0.91
0.97
1.06
1.17
1.27
1.42
1.46
1.23
1.42
- -
Tangible Book Value per Share
18
18
18
18
18
20
20
20
20
21
20
20
20
19
17
- -
Basic Weighted Avg Shares
22
19
24
26
23
23
24
29
28
29
31
33
33
31
38
47
Sales/Revenue/Turnover
7.22
9.77
11.7
11.29
13
15.24
15.78
13.64
15.82
14.79
17.26
16.94
10.75
8.14
12.81
16.69
Operating Margin (%)
- -
- -
1
- -
- -
1
1
1
1
1
1
1
1
1
1
1
Depreciation Expense
1
2
2
3
3
4
3
3
4
4
4
5
3
3
4
7
Net Income, GAAP
15.1
8.21
- -
11.33
3.48
10.15
3.73
12.28
12.12
15.45
21.4
17.86
10.27
8.17
20.63
15.4
Effective Tax Rate (%)
5.94
8.68
8.95
9.92
13.48
16.02
10.6
10.21
14.16
12.79
13.78
14.03
9.98
8.16
10.77
14.31
Profit Margin (%)
6
7
7
9
11
14
16
17
19
20
22
25
27
19
19
24
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
15
16
18
20
23
27
29
31
33
36
38
40
41
34
36
41
Total Equity
9.07
11.04
- -
13.47
13.52
12.87
13.42
11.78
12.23
10.49
11.27
11.91
7.83
6.17
11.11
17.28
Return on Invested Capital (%)
20.4
16.88
- -
16.58
17.73
18.04
11.1
12
14.85
12.64
13.26
13.67
9.12
8.03
15.01
21.77
Return on Capital (%)
20.71
17.06
15.4
16.58
17.73
18.04
11.1
12
14.89
12.69
13.3
13.69
9.13
8.03
15.04
21.85
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.78%
2.43%
12.86%
Free Cash Flow
-178.73%
-411.49%
39.4%
Net Income, GAAP
11.02%
17.06%
64.2%
Sales/Revenue/Turnover
7.79%
9.78%
23.51%
Total Cash Common Dividend
9.9%
4.37%
12.41%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
31
2024
- -
- -
- -
- -
38
2025
- -
- -
- -
- -
47

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.14
2024
- -
- -
- -
- -
0.25
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.09
2024
- -
- -
- -
- -
0.11
2025
- -
- -
- -
- -
- -
Similar Companies
KRBL Limited (KRBL.NS)
Nepra Foods Inc. (NPRFF)
Guangdong Haid Group Co., Limited (002311.SZ)
Bon Natural Life Limited (BON)
Zydus Wellness Limited (ZYDUSWELL.BO)
Wei Chuan Foods Corporation (1201.TW)
Business
Anpario plc manufactures and distributes natural sustainable animal feed additives for health, nutrition and biosecurity to livestock and aquaculture producers worldwide. The company offers solutions across poultry, ruminant, swine, aqua and feed mill segments; its product categories encompass health and performance with brands including Orego-Stim Range, Orego-Stim Range (Aqua), pHorce Range, Salkil Range, Optomega Range and Genex Range; toxin management featuring Anpro Range and Anpro Advance; feed quality with pHorce Range, Salgard Range, Mastercube Range, Moldgard, Oxigard Range and Feedzyme Range; and hygiene and insect control technologies. Anpario operates in over 80 countries through established sales and distribution networks, including wholly owned subsidiaries, with manufacturing facilities in the United Kingdom and the United States. Founded in 1996 and headquartered in Worksop, Nottinghamshire, United Kingdom, the company, listed on the AIM market of the London Stock Exchange (ANP.L), recently completed the acquisition of Bio-Vet Inc. in 2024 for up to US$7.3 million, enhancing its ruminant sector presence in the US dairy market with complementary probiotics such as Generator and calcium boluses like QuadriCal, alongside a new 25,000 square feet production facility in Barneveld, Wisconsin. This transaction supports species diversification, international expansion of Bio-Vet's on-farm products to smaller commercial farmers, and operational resilience in North America, while delivering immediate earnings enhancement amid strong 2025 interim revenue growth of 34% to £22.7 million.